Saturday, May 9, 2026

"central-drug-authority"

Dr Reddy’s Lab gets nod to carry out bioequivalence study of semaglutide injection

The pharma firm had approached the Drugs Controller General of India (DCGI)seeking a waiver for the phase-III clinical trial of the drug and its market authorisation.

Latest News

Arvind Kejriwal compares Modi to Aurangzeb amid ED raids in Punjab

13 mins ago
Same-sex Hindu-Muslim couple seeks police protection in Gurugram

17 mins ago
JBIET and Bhaskar Engineering College celebrate Placement Day 2026

28 mins ago
Seven engineers reinstated in Bhopal 90-degree overbridge controversy

29 mins ago
Kalasagaram hosts 12-hour Carnatic music festival in Hyderabad

31 mins ago
Suvendu Adhikari says rebuilding Bengal is his top priority

39 mins ago
‘Awaken the core’ theme announced for Sunburn Festival 2026

45 mins ago
‘Years of hard work paid off’: Makhanlal Sarkar’s family feels ‘proud’ on recognition from PM Modi

50 mins ago